FDA Clears Masimo Pediatric Brain Function Monitoring and EEG Sensor
The FDA has cleared Masimo SedLine brain function monitoring for pediatric patients under the age of 18 and its SedLine Pediatric EEG Sensor.
Read MoreFeb 28, 2022 | Clearances | 0 |
The FDA has cleared Masimo SedLine brain function monitoring for pediatric patients under the age of 18 and its SedLine Pediatric EEG Sensor.
Read MoreFeb 16, 2022 | Medical Equipment | 0 |
WHO has supplied an additional 180 oxygen concentrators, 2,000 pulse oximeters, and other medical equipment to outpatient units in villages in Georgia.
Read MoreJan 28, 2022 | Patient Care Equipment | 0 |
The severity of COVID-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from pulse oximeters.
Read MoreJan 18, 2022 | Patient Care Equipment | 0 |
Masimo’s technology showed no clinically significant bias on user ethnicity, based on data collected from black and white volunteer subjects.
Read MoreJan 5, 2022 | General Testing Equipment, Testing & Calibration | 0 |
Vital signs monitors frequently top the U.S. FDA’s recall list, due to their ability to cause patient harm. In fact, the FDA database includes many reports of non-invasive blood pressure failures, incorrect oxygen values, electrocardiogram (ECG) signal errors, and more. This compounds the importance of ensuring patient monitoring systems are accurate and safe to use.
Read More